NCT03828994 is a NA clinical trial of Tech-PN in Pelvic Inflammatory Disease, sponsored by Johns Hopkins University.

Who is sponsoring NCT03828994?

NCT03828994 is sponsored by Johns Hopkins University.

What drugs are being tested in NCT03828994?

Interventions in NCT03828994: Tech-PN.

What condition does NCT03828994 study?

NCT03828994 studies Pelvic Inflammatory Disease.

Is NCT03828994 still recruiting?

NCT03828994 is currently active, enrolled. Last updated 14 November 2025.

Last reviewed 2025-11-14 · How we verify

NCT03828994

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Technology Based Community Health Nursing(TECH-N) to Prevent Recurrent STIs After PID II

Active, enrolled NA Last updated 14 November 2025

What this trial tests

NA trial testing Tech-PN in Pelvic Inflammatory Disease in 150 participants. Participants enrolled and being followed up; not accepting new ones.

Timeline

10 February 2019

Primary endpoint
31 December 2026

31 March 2027

Quick facts

Lead sponsor	Johns Hopkins University
Phase	NA
Status	Active, enrolled
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	prevention
Enrollment	150
Start date	10 February 2019
Primary completion	31 December 2026
Estimated completion	31 March 2027
Sites	1 location across United States

Drugs / interventions tested

Tech-PN

Conditions studied

Pelvic Inflammatory Disease — all drugs for Pelvic Inflammatory Disease →

Sponsor

Johns Hopkins University

Who can join

Adults 13 to 25, female only, with Pelvic Inflammatory Disease. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The investigators are enrolling 150 young women 13-25 years old diagnosed with pelvic inflammatory disease (PID) in Baltimore to receive community health nurse (CHN) clinical support visits and short messaging system communication support for 30 days. The investigators' intervention group(TECH-PN) will receive additional testing and treatment in the field. The investigators hypothesize that repackaging the recommended Centers for Disease Control and Prevention (CDC) follow-up visit using a technology-enhanced community health nursing intervention (TECH-N) with integration of an evidence-based sexually transmitted infection (STI) prevention curriculum will reduce rates of short-term repeat infection by improving adherence to PID treatment and reducing unprotected intercourse and be more cost-effective compared with outpatient standard of care (and hospitalization).

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Pelvic Inflammatory Disease

Currently open trials in the same condition.

NCT06756568 — The Diagnostic Utility of Ultrasound in Pelvic Inflammatory Disease (PID) · active not recruiting
NCT06360965 — Clinical Trial of Acupoint Application in Improving the Sequelae of Pelvic Inflammatory Disease and Chronic Pelvic Pain · NA · recruiting
NCT04567771 — Comparison of Proton or Intensity Modulated Radiation Therapy After Surgery for Endometrial or Cervical Cancer · NA · recruiting

Other Johns Hopkins University trials

Trials by the same sponsor.

NCT06236542 — Tracheostomy Robotics and Cutting-edge Health Education for Airway Safety · NA · not yet recruiting
NCT07532252 — Daridorexant for Alcohol Use Disorder · Phase 2 · not yet recruiting
NCT06687655 — Impact of Exogenous Ketones on Sleep Apnea · Phase 1, PHASE2 · not yet recruiting
NCT07079111 — 3D Printed Occlusal Splints for Intraoperative Use · NA · not yet recruiting
NCT02998502 — The Use of a FDA Cleared, Drug-free, Breathing System for Anxiety and Panic Disorders in Children and Teens · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03828994 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Johns Hopkins University
Last refreshed: 14 November 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03828994.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing